Attending Digital Health Festival? Click here.
The voice of business news for healthcare
Male nurse consulting elderly male patient

Nurse prescribing in 2026: what practice leaders should prepare for now

×

Share this article

read time 4 min

Key takeaways

  • In 2025, the Nursing and Midwifery Board of Australia approved a new prescribing pathway for eligible Registered Nurses
  • Registered Nurses must complete approved postgraduate education and prescribe within a formal collaborative arrangement with a doctor or nurse practitioner
  • The first cohort is expected to begin prescribing in mid-2026
  • The reform aims to address workforce shortages, rising chronic disease and access gaps
  • Practice owners must prepare for workflow, governance and indemnity implications ahead of implementation

Australia’s primary care system is under sustained pressure. GP shortages persist across metropolitan and rural areas, chronic disease continues to rise, and access gaps remain across aged care, disability and community settings.

In response, the Nursing and Midwifery Board of Australia has approved a new prescribing pathway for Registered Nurses, with the first cohort expected to begin prescribing in mid-2026.

The reform expands scope, but does not create independent nurse prescribers. Registered Nurses must complete approved postgraduate education and prescribe within a formal collaborative arrangement with a doctor or nurse practitioner.

For healthcare leaders, the question is not whether nurses should prescribe. It is how this model will work in practice, and what it means for governance, workflow and business sustainability.

What has changed

Under the new pathway, eligible Registered Nurses will be authorised to prescribe certain medicines within defined clinical parameters.

Key elements of the model include:

  • Completion of approved postgraduate education
  • Prescribing limited to an endorsed scope of practice
  • A formal collaborative arrangement with a medical practitioner or nurse practitioner
  • Compliance with professional standards and regulatory oversight

This is structured, conditional prescribing. It is not autonomous or unsupervised practice.

Annie Butler, Federal Secretary of the Australian Nursing and Midwifery Federation, said the pathway was introduced in response to growing system demand.

“The RN prescribing pathway was designed to respond to workforce shortages and to improve timely access to care, due to increasing demand across primary and aged care. Australia is experiencing sustained pressure from an ageing population, rising rates of chronic disease, and reduced access to general practitioner (GP) appointments in many regions.”

Why the reform now

The broader system context matters.

Australia faces workforce shortages across general practice and aged care. An ageing population is driving more complex, long-term health needs. Rural and remote communities continue to experience limited access to timely medical care.

Expanding Registered Nurse scope is positioned as one lever to improve responsiveness without compromising safety.

“In residential aged care particularly, delays in medication charting and renewals have contributed to avoidable hospital transfers and after-hours prescribing burdens. The pathway aims to formalise and regulate medication management activities already performed by experienced Registered Nurses, improving efficiency and enhancing continuity of care across high demand settings,” Butler said.

Expanding scope does not remove system pressure. It redistributes it.

For practice owners and healthcare executives, the operational design of this reform will determine whether it relieves strain or introduces new complexity.

Female nurse administers medication to elderly patient

How the model will work day to day

In practical terms, Registered Nurse prescribing will sit within team-based care models.

The requirement for a formal collaborative arrangement is central. Prescribing decisions must occur within a defined professional relationship with a doctor or nurse practitioner. That implies:

  • Agreed protocols and clinical boundaries
  • Clear documentation processes
  • Defined escalation pathways
  • Shared governance responsibilities

For practices, this means policy updates, supervision structures and documentation workflows must be reviewed well before mid-2026.

Indemnity coverage will also require attention. Practice owners will need to confirm insurance arrangements reflect expanded scope and shared accountability.

 

What this means for GPs and nurse practitioners

For General Practitioners, the reform may offer relief in specific contexts. Routine medication management, repeat prescribing within established care plans and chronic disease follow-up could, in time, be distributed more effectively across the team.

However, collaborative arrangements do not eliminate oversight responsibilities. Governance remains shared. Documentation standards must be clear. Clinical leadership must be explicit.

For nurse practitioners, the model creates another layer within advanced practice hierarchies. Clear delineation between Registered Nurse prescribing scope and nurse practitioner autonomy will be essential to avoid confusion.

This reform does not flatten roles. If anything, it makes role clarity critical.

Commercial and operational implications

From a business perspective, Registered Nurse prescribing could:

  • Improve appointment throughput
  • Reduce wait times for routine medication management
  • Enhance continuity of care in aged care and community settings
  • Strengthen multidisciplinary team models

But it may also introduce:

  • Additional training costs
  • Governance and compliance workload
  • Documentation complexity
  • Potential indemnity premium adjustments

The financial impact will vary by setting.

Rural practices may see access benefits sooner. Large multidisciplinary clinics may integrate prescribing into established team-based models more easily. Smaller practices will need to weigh training investment against projected demand.

The reform is unlikely to transform revenue streams overnight. It is more likely to incrementally reshape workflow design and service allocation.

“From an ANMF perspective, consideration should be given to how the reform may affect workforce utilisation, supervision structures, clinical governance, and team-based models of care,” Butler said.

Governance is the real work

Scope expansion in healthcare is rarely just about access. It is about accountability.

Practice leaders should begin preparing now by:

  • Reviewing collaborative agreement templates
  • Clarifying supervision and escalation protocols
  • Confirming indemnity arrangements
  • Mapping prescribing workflow within electronic medical record systems
  • Identifying suitable Registered Nurses for postgraduate training pathways

Waiting until mid-2026 will compress implementation timelines unnecessarily.

Leadership takeaway: design before demand

Registered Nurse prescribing is not a sudden disruption. It is a structured reform with a defined education pathway and collaborative guardrails.

Whether it relieves pressure or creates friction will depend on preparation.

Practices that treat this as a governance exercise, not just a workforce announcement, will be better positioned to integrate prescribing safely and sustainably.

Healthcare reform rarely removes complexity. It reallocates it. Practices that plan early will feel the difference first.


Sources:

New standard to enable registered nurse prescribing
https://www.ahpra.gov.au/News/2025-05-30-RNs-poised-to-prescribe-in-major-leap-for-healthcare-access-and-delivery.aspx

×

Share this article